Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2018 1
2020 2
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC; KEYNOTE-189 Investigators. Gandhi L, et al. N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16. N Engl J Med. 2018. PMID: 29658856 Free article. Clinical Trial.
Normal tissue content impact on the GBM molecular classification.
Madurga R, García-Romero N, Jiménez B, Collazo A, Pérez-Rodríguez F, Hernández-Laín A, Fernández-Carballal C, Prat-Acín R, Zanin M, Menasalvas E, Ayuso-Sacido Á. Madurga R, et al. Among authors: collazo a. Brief Bioinform. 2021 May 20;22(3):bbaa129. doi: 10.1093/bib/bbaa129. Brief Bioinform. 2021. PMID: 32632447
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
Romero A, Jantus-Lewintre E, García-Peláez B, Royuela A, Insa A, Cruz P, Collazo A, Pérez Altozano J, Vidal OJ, Diz P, Cobo M, Hernández B, Vázquez Estevez S, Benítez G, Guirado M, Majem M, Bernabé R, Ortega AL, Blasco A, Bosch-Barrera J, Jurado JM, García González J, Viteri S, Garcia Giron C, Massutí B, Lopez Martín A, Rodriguez-Festa A, Calabuig-Fariñas S, Molina-Vila MÁ, Provencio M. Romero A, et al. Among authors: collazo a. Mol Oncol. 2021 Jan;15(1):43-56. doi: 10.1002/1878-0261.12832. Epub 2020 Nov 13. Mol Oncol. 2021. PMID: 33107189 Free PMC article.
Association of quality of life with performance status, circadian rhythm, and activity level of lung cancer patients using wearable devices as ambulatory monitoring.
Torrente M, Sousa PA, Franco F, Mensalvas E, Calvo V, Collazo A, Parejo C, Campos M, Pimentao J, Provencio M. Torrente M, et al. Among authors: collazo a. Clin Med (Lond). 2022 Jul;22(Suppl 4):36-37. doi: 10.7861/clinmed.22-4-s36. Clin Med (Lond). 2022. PMID: 36220256 Free PMC article. No abstract available.
An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study.
Torrente M, Sousa PA, Hernández R, Blanco M, Calvo V, Collazo A, Guerreiro GR, Núñez B, Pimentao J, Sánchez JC, Campos M, Costabello L, Novacek V, Menasalvas E, Vidal ME, Provencio M. Torrente M, et al. Among authors: collazo a. Cancers (Basel). 2022 Aug 22;14(16):4041. doi: 10.3390/cancers14164041. Cancers (Basel). 2022. PMID: 36011034 Free PMC article.
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.
Blanco-Aparicio C, Collazo AM, Oyarzabal J, Leal JF, Albarán MI, Lima FR, Pequeño B, Ajenjo N, Becerra M, Alfonso P, Reymundo MI, Palacios I, Mateos G, Quiñones H, Corrionero A, Carnero A, Pevarello P, Lopez AR, Fominaya J, Pastor J, Bischoff JR. Blanco-Aparicio C, et al. Among authors: collazo am. Cancer Lett. 2011 Jan 28;300(2):145-53. doi: 10.1016/j.canlet.2010.09.016. Epub 2010 Nov 3. Cancer Lett. 2011. PMID: 21051136